Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 8(1): 11487, 2018 07 31.
Article in English | MEDLINE | ID: mdl-30065302

ABSTRACT

Magnetoliposomes (MLs) were synthesized and tested for longitudinal monitoring of transplanted pancreatic islets using magnetic resonance imaging (MRI) in rat models. The rat insulinoma cell line INS-1E and isolated pancreatic islets from outbred and inbred rats were used to optimize labeling conditions in vitro. Strong MRI contrast was generated by islets exposed to 50 µg Fe/ml for 24 hours without any increased cell death, loss of function or other signs of toxicity. In vivo experiments showed that pancreatic islets (50-1000 units) labeled with MLs were detectable for up to 6 weeks post-transplantation in the kidney subcapsular space. Islets were also monitored for two weeks following transplantation through the portal vein of the liver. Hereby, islets labeled with MLs and transplanted under the left kidney capsule were able to correct hyperglycemia and had stable MRI signals until nephrectomy. Interestingly, in vivo MRI of streptozotocin induced diabetic rats transplanted with allogeneic islets demonstrated loss of MRI contrast between 7-16 days, indicative of loss of islet structure. MLs used in this study were not only beneficial for monitoring the location of transplanted islets in vivo with high sensitivity but also reported on islet integrity and hereby indirectly on islet function and rejection.


Subject(s)
Contrast Media/metabolism , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Islets of Langerhans/metabolism , Islets of Langerhans/pathology , Magnetite Nanoparticles/administration & dosage , Animals , Cells, Cultured , Diabetes Mellitus, Experimental/chemically induced , Hyperglycemia/metabolism , Hyperglycemia/pathology , Insulin/metabolism , Islets of Langerhans Transplantation/methods , Liver/metabolism , Liver/pathology , Longitudinal Studies , Magnetic Resonance Imaging/methods , Portal Vein/metabolism , Portal Vein/pathology , Rats , Rats, Inbred Lew , Rats, Wistar , Streptozocin/pharmacology
2.
Rev Bras Parasitol Vet ; 21(3): 243-8, 2012.
Article in English | MEDLINE | ID: mdl-23070434

ABSTRACT

Rangelia vitalii is a protozoon that causes diseases in dogs, and anemia is the most common laboratory finding. However, few studies on the biochemical changes in dogs infected with this protozoon exist. Thus, this study aimed to investigate the biochemical changes in dogs experimentally infected with R. vitalii, during the acute phase of the infection. For this study, 12 female dogs (aged 6-12 months and weighing between 4 and 7 kg) were used, divided in two groups. Group A was composed of healthy dogs (n = 5); and group B consisted of infected animals (n = 7). Blood samples were collected on days 0, 10, 20 and 30 after infection, using tubes without anticoagulant to obtain serum and analyze the biochemical parameters. An increase in alanine aminotransferase (ALT) on day 20 (P < 0.05) was observed. Also, increased creatine kinase (CK) and aspartate aminotransferase (AST) levels were observed throughout the experimental period (P < 0.05). No changes in the serum gamma-glutamyltransferase, urea and creatinine levels were observed. Thus, is possible to conclude that experimental infection with R. vitalii in dogs causes changes to the biochemical profile, with increased ALT, AST and CK enzyme levels.


Subject(s)
Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Creatine Kinase/blood , Dog Diseases/blood , Dog Diseases/parasitology , Protozoan Infections, Animal/blood , Acute Disease , Animals , Dog Diseases/enzymology , Dogs , Female , Protozoan Infections, Animal/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...